Qin Li

Qin Li

Auto-generated profile, based on publicly available information

Qin Li

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2024 in Acta Tropica
Verified
Journal Article
Open access
QLQin Li
Qin Li
YLYin-Long Li
Yin-Long Li
YGYing-Su Guo
Ying-Su Guo
SLShi-Zhen Li
Shi-Zhen Li
QWQiang Wang
Qiang Wang
Jing XuJing Xu
Jing Xu
The WHO aims to eliminate schistosomiasis as a public health problem by 2030. Based on the Global Burden of Disease 2021 (GBD 2021), this study assesses the global distribution of schistosomiasis burden to guide policy and resource allocation. Schistosomiasis burden and social-demographic indexes (SDIs) data were extracted from GBD 2021 study. Smoothing spline models were used to examine the relationship between age-standardized prevalence rates (ASPR), DALY rates, mortality rates (ASMR), and SDI. Future burden predictions till 2030 were made using a Bayesian age-period-cohort model. Predictions and their 95% certainty intervals were used to determine whether the region can meet the target by 2030. Globally, the burden of schistosomiasis was substantial (prevalence: 151.38 million; DALYs: 1,746,333.31; deaths: 12857.57) in 2021. Africa accounted for most burden (Prevalence: 84.25%; DALYs: 87.92%; Deaths: 87.28%). Among all age groups, individuals aged 15 to 24 years old bear the heaviest burden in 2021. The ASPR, Age-standardized DALY rate and ASMR were inversely correlated to the SDIs across different super regions (r = -0.72, P < 0.00; r = -0.71, P <0.00; r = -0.71, P <0.00) and countries and territories (r = 0.02, P =0.85; r = -0.48, P <0.00; r = -0.72, P <0.00). According to model results, the burden of schistosomiasis in most regions will continue to decline in the future, while it in regions with high-income presented slightly rising. Despite significant progress, further effects are needed to achieve the 2030 goal across the world. Additionally, the rising ASR of DALY of schistosomiasis in regions with high-income warrants attentions.

3 June 2024 in medRxiv
Verified
Preprint
Open access
PDF file
QLQin Li
Qin Li
YLYin-Long Li
Yin-Long Li
SGSu-Ying Guo
Su-Ying Guo
SLShi-Zhen Li
Shi-Zhen Li
QWQiang Wang
Qiang Wang
Jing XuJing Xu
Jing Xu
Background: As the deadline for eliminating schistosomiasis approaches, more targeted and effective interventions should be proposed. We aimed to understand the burden among various gender, ages, countries, and continents and to analyze the trends in the burden of schistosomiasis from 1990 to 2041. Methods: This study utilizes data from the Global Burden of Disease (GBD) 2021 to analyze the schistosomiasis burden trends from 1990 to 2021, including age-standardized rates of prevalence, Disability-Adjusted Life Years (DALYs), and death of different genders, ages, and regions. Data of schistosomiasis related anemia was also extracted and analyzed. Bayesian age-period-cohort (BAPC) models were used to assess and project the age standardized rates of prevalence, DALYs and death till 2041. Results: Globally, the age-standardized rates of prevalence, DALYs, and death of schistosomiasis all present a declining trend. Individuals aged 15 to 29 years old present the highest age-standardized rates of prevalence and DALYs. The burden of schistosomiasis varies inversely with socio-economic development. The Years Lived with Disability (YLDs) rate for schistosomiasis-related anemia increases with the burden of schistosomiasis. The age-standardized rates of prevalence, DALYs, and death might tend to decline until 2041 in the world, Africa, Asia, and the Americas. Conclusions: The burden of schistosomiasis is clustered in the 15 to 29 age group, which represents the strongest labor force. Additionally, reproductive-aged women also experience a significant disease burden. Targeted interventions including preventive chemotherapy, health behavior change, and communications should be proposed and covered this risk population. Author summary: Schistosomiasis primarily affects more than 200 million people in Africa, Asia, and the Americas. To achieve the World Health Organization’s (WHO) 2030 target of eliminating schistosomiasis as a public health problem globally, understanding the distribution of schistosomiasis burden is crucial. In this study, we employed data from the Global Burden of Disease Study 2021 to analyze the burden of schistosomiasis across different regions, countries, genders, and age groups. Our analysis reveals that both the age standardized rates of prevalence and Disability-Adjusted Life Years (DALYs) of schistosomiasis reach the peak among individuals aged 15-29 years, who represent the highest potential for labor force participation and reproduction. The disease burden increases with the decline of Socio-demographic Index (SDI). However, countries with higher levels of healthcare level exhibit lower schistosomiasis-related anemia Years Lived with Disability (YLDs) rates. Most endemic areas in Asia and the Americas are supposed to achieve the target of schistosomiasis elimination before 2030, but Africa faces challenges in meeting it. Therefore, we advised endemic countries with lower SDIs to implement targeted interventions for the 15 to 29 age group. Meanwhile, improving healthcare level also be important to decrease the impact of schistosomiasis.